BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.89B |
| 2 |
Amazon
AMZN
|
+$3.22B |
| 3 |
Microsoft
MSFT
|
+$2.88B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.68B |
| 5 |
Visa
V
|
+$2.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$1.44B |
| 2 |
AZPN
Aspen Technology Inc
AZPN
|
+$914M |
| 3 |
ALTR
Altair Engineering Inc
ALTR
|
+$816M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$689M |
| 5 |
Williams-Sonoma
WSM
|
+$683M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.85% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 9.94% |
| 5 | Industrials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
TScan Therapeutics
TCRX
$54.7M
| $6.73M | ﹤0.01% |
4,878,833
-82,867
| -2% | -$179K |
|
3402
Zentalis Pharmaceuticals
ZNTL
$317M
| $6.72M | ﹤0.01% |
4,229,497
-8,592
| -0.2% | -$18.5K |
|
3403
Larimar Therapeutics
LRMR
$412M
| $6.72M | ﹤0.01% |
3,123,988
-141,917
| -4% | -$449K |
|
3404
Contango Silver & Gold Inc
CTGO
$542M
| $6.7M | ﹤0.01% |
656,622
-5,959
| -0.9% | -$60.8K |
|
3405
eGain
EGAN
$180M
| $6.7M | ﹤0.01% |
1,380,908
-29,112
| -2% | -$165K |
|
3406
Immunocore
IMCR
$1.8B
| $6.69M | ﹤0.01% |
225,545
-47,235
| -17% | -$1.42M |
|
3407
Stereotaxis
STXS
$133M
| $6.67M | ﹤0.01% |
3,791,464
-106,421
| -3% | -$227K |
|
3408
State Street Materials Select Sector SPDR ETF
XLB
$8.67B
| $6.64M | ﹤0.01% |
154,456
+31,798
| +26% | +$1.39M |
|
3409
Gencor Industries
GENC
$224M
| $6.63M | ﹤0.01% |
545,327
-10,003
| -2% | -$142K |
|
3410
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$735M
| $6.62M | ﹤0.01% |
176,692
-1,141
| -0.6% | -$42.3K |
|
3411
Clarus
CLAR
$128M
| $6.6M | ﹤0.01% |
1,761,216
-19,972
| -1% | -$89.6K |
|
3412
Torrid Holdings
CURV
$253M
| $6.57M | ﹤0.01% |
1,199,134
+80,056
| +7% | +$480K |
|
3413
Sanara MedTech
SMTI
$239M
| $6.52M | ﹤0.01% |
211,066
-3,933
| -2% | -$134K |
|
3414
Atossa Therapeutics
ATOS
$22.9M
| $6.48M | ﹤0.01% |
641,691
-8,946
| -1% | -$109K |
|
3415
Stevanato
STVN
$5.38B
| $6.46M | ﹤0.01% |
316,578
-171,633
| -35% | -$3.65M |
|
3416
Pebblebrook Hotel Trust 6.375% Series E Preferred Shares
PEB.PRE
$88.2M
| $6.45M | ﹤0.01% |
+376,226
| New | +$7.16M |
|
3417
Virco
VIRC
$95.2M
| $6.45M | ﹤0.01% |
681,787
-13,896
| -2% | -$145K |
|
3418
Ericsson
ERIC
$31.7B
| $6.44M | ﹤0.01% |
829,645
+560,824
| +209% | +$4.53M |
|
3419
Energy Transfer Partners
ET
$69.2B
| $6.42M | ﹤0.01% |
345,393
+47,193
| +16% | +$919K |
|
|
SBT
3420
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $6.42M | ﹤0.01% |
1,325,858
-77,249
| -6% | -$365K |
|
|
MAZE
3421
Maze Therapeutics
MAZE
$1.55B
| $6.41M | ﹤0.01% |
+582,588
| New | +$7.01M |
|
3422
Lexeo Therapeutics
LXEO
$375M
| $6.39M | ﹤0.01% |
1,842,232
+20,266
| +1% | +$89.8K |
|
3423
Red Cat Holdings
RCAT
$1.21B
| $6.39M | ﹤0.01% |
1,086,626
-242,003
| -18% | -$1.94M |
|
|
LKFT
3424
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $6.38M | ﹤0.01% |
253,951
-170,713
| -40% | -$4.31M |
|
3425
Geospace Technologies
GEOS
$92.6M
| $6.36M | ﹤0.01% |
882,005
-12,888
| -1% | -$111K |
|
Similar funds
BlackRock's Q1 2025 Portfolio in Review
As of Q1 2025, BlackRock held 5,602 positions worth $4.76T, down 3.7% from $4.94T the previous quarter. Its ten largest holdings account for 25% of the portfolio.
BlackRock's Q1 2025 filing shows 211 new, 1,923 increased, 2,656 reduced and 168 closed positions. Its largest new stake was Sandisk: 14,395,767 shares worth $685M. The largest sale was iShares Core MSCI Total International Stock ETF, an estimated $1.44B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q1 2025 buy was Sandisk: 14,395,767 shares worth $685M.
- BlackRock added most to Apple in Q1 2025, an estimated $3.89B increase.
- BlackRock's biggest Q1 2025 reduction was iShares Core MSCI Total International Stock ETF, cutting an estimated $1.44B.
- BlackRock fully exited Aspen Technology Inc in Q1 2025, selling an estimated $914M.
- BlackRock's ten largest holdings make up 25% of its $4.76T portfolio in Q1 2025.
- BlackRock opened 211 new positions and closed 168 in Q1 2025.
- BlackRock's portfolio value fell 3.7% quarter-over-quarter to $4.76T.
Based on BlackRock's 13F filing for Q1 2025, filed 2 May 2025.